期刊文献+

血清肌钙蛋白I质控物的研究 被引量:2

The study of serum cardiac troponin I control materials
下载PDF
导出
摘要 目的评价自制血清肌钙蛋白I(cTnI)质控物均匀性和稳定性。方法按实验设计收集混合血清,分装-20℃贮存。参照CNAS-GL03《能力验证样品均匀性和稳定性评价指南》,对质控物的均匀性进行评价;运用恒温加速试验研究稳定性。结果质控物均匀性差异无统计学意义(P>0.05)。恒温加速试验显示,血清cTnI降解随时间变化符合化学动力学一级反应,根据Arrhenius方程推测4℃贮存7d,-20℃贮存有效期为19个月;监测质控物9个月,与恒温加速试验结果一致。结论自制血清cTnI质控物均匀性、稳定性良好,可用于临床室内质量控制。 Objective To prepare a set of serum cardiac troponin I quality control materials for testing and evaluate the homogeneity and stability.Methods Mixed serum were collected,filtered,distributed,storaged at-20 ℃ according to the experimental design.The homogeneity of serum pools was evaluating according to the CNAS-GL03 Guidance.The stability of cTnI in human serum was examined using an accelerated stability testing protocol according to the Arrhenius equation.Further,the effect of stability was verified by long term test.Results In the homogeneity evaluation the results showed that there were insignificant difference between the control materials(P〉0.05).Stability analysis,the control should not exceed 2times by freeze-thawing;constant temperature accelerated test results showed that the serum levels of cTnI degraded in accordance with the change of chemical first-order reaction kinetics.Arrhenius-plots indicated that the cTnI control materials were stable for at least 7days at 4 ℃ and 19 months at-20 ℃,respectively.Control materials were monitored for 9months,the results are stable,and consistent with the constant temperature acceleration.Conclusion The homogeneity and stability of serum cTnI is good and can be used in clinical quality control.
出处 《国际检验医学杂志》 CAS 2015年第14期1969-1970,共2页 International Journal of Laboratory Medicine
基金 南通大学自然科学项目(13Z018)
关键词 血清肌钙蛋白 质控物 均匀性 稳定性 serum cTnI control stability homogeneity
  • 相关文献

参考文献12

  • 1Christenson RH, Duh SIt, Apple FS, et al. Standardization of car- diac troponin I assays:round Robin o{ ten candidate reference rna- terials[Jl. Clin Chem,2001,47(3) :431-437. 被引量:1
  • 2Christenson RH, Duh SH, Apple FS, et al. Toward standardization of cardiac troponin I measurements part II : assessing commut- ability of candidate reference materials and harmonization of cardi- ac troponin I assays[J]. Clin Chem, 2006,52 (9) : 1685-1692. 被引量:1
  • 3Bunk DM,Welch MJ. Characterization of a new certified reference material for human cardiac troponin I[J]. Clin Chem, 2006,52 (2) :212-219. 被引量:1
  • 4才蕾,武建伟,邓秋菊,方琦,王继华,唐时幸.人心肌肌钙蛋白I冻干质控品的制备及评价[J].临床检验杂志,2014,32(8):615-617. 被引量:6
  • 5Tate JR, Bunk DM, Christenson RH, et al. Standardisation of car diac troponin I measurement: past and present[J]. Pathology, 2010,42(5) :402-408. 被引量:1
  • 6Zhang S,Zeng J, Zhang C, et al. Commutability of possible exter nal quality assessment materials for cardiac troponin measurement :Jj. PLoS 0ne,2014,9(7) :e102046. 被引量:1
  • 7中国合格评定委员会.CNAS-GL03《能力验证样品均匀性和稳定性评价指南》[s].2006. 被引量:1
  • 8Peleg M, Norrnand MD,cooradini MG, et al. The arrhenius equa- tion revisited[J]. Crit Rev FOOd Sci Nutr,2012,52(9) .-830-851,. 被引量:1
  • 9杨雪,张传宝,王薇,汪静,赵海舰,王治国.我国心肌损伤标志物不同检测系统质量水平调查[J].临床检验杂志,2013,31(1):65-67. 被引量:5
  • 10周涛,王晓云,杨红英,邓丹琪,陈孝红,梁先念,高颖斐,杨成凤.类风湿性关节炎类风湿因子对检测cTnI的影响研究[J].国际检验医学杂志,2009,30(11):1130-1130. 被引量:5

二级参考文献22

  • 1潘柏申.心脏标志物检测标准化研究进展[J].中华检验医学杂志,2007,30(4):467-471. 被引量:7
  • 2李玉彬,张春明,王德芝.重组人心肌肌钙蛋白Ⅰ基因工程菌的构建[J].临床检验杂志,2007,25(4):273-275. 被引量:5
  • 3Krahn J, Parry D, Leroux M, Dalton J. High percentage of false positive cardiac troponin Ⅰ results in patients with rheumatoid factor. Clin Biochem, 1999,32 : 477-480. 被引量:1
  • 4Onuska KD, Hill SA. Effect of rheumatoid factor on cardiac troponin 1 measurements using two commercial measurement systems. Clin Chem,2000,46:307-308. 被引量:1
  • 5Dasgupta A,Banerjee SK,Datta P. False-positive troponin Ⅰ in the MEIA due to thc presence of rheumatoid factors in serum. Am J Clin Pathol, 1999,112 : 753-756. 被引量:1
  • 6Katwa G, Komatireddy G, Walker SE. False positive elevation of cardiac troponin Ⅰ in seropositive rheumatoid arthritis. J Rheumatol,2001,28:2750-2751. 被引量:1
  • 7Apple FS, Maryann M. The diagnostic utility of cardiac biomarkers in detecting myocardial infarction [J]. Clinical Cornerstone, 2005,7[Suppl 1]:S25-S30. 被引量:1
  • 8Ferguson J L, Beckett G J, Stoddart M, et al. Myocardial infarction redefined:the new ACC/ESC definition, based on cardiac troponin,increases the apparent incidence of infarction. 被引量:1
  • 9Russell E,Zeihen M,Wergin S,et al. Patients receiving etanercept may develop antibodies that interfere with monoelonal antibody laboratory assays. Arthritis Rheum, 2000,43 : 944. 被引量:1
  • 10Jaffe AS, Ordonez-Llanoos J. High-sensitivity cardiac troponin : from the- ory to clinical practice[J ]. Rev Esp Cmxtiol, 2013, 66(9) : 687-691. 被引量:1

共引文献13

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部